The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, multicenter, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HS-10382 (TERN-701) in patients (pts) with chronic myeloid leukemia (CML).
 
Weiming Li
Research Funding - Hansoh
 
Na Xu
No Relationships to Disclose
 
Zhongyuan Xu
No Relationships to Disclose
 
Yanli Zhang
No Relationships to Disclose
 
Junmin Li
No Relationships to Disclose
 
Huanling Zhu
No Relationships to Disclose
 
Li Zheng
No Relationships to Disclose
 
Xiaojing Yan
No Relationships to Disclose
 
Xin Du
No Relationships to Disclose
 
Hongying Wei
Employment - Hansoh Pharma
 
Qiqi Huang
Employment - Hansoh Pharma
 
Jiawei Wei
Employment - Hansoh Pharma
 
Yu Hu
Research Funding - Pfizer; Sanofi